Voyageur Pharmaceuticals Ltd. (VYYRF)
OTCMKTS · Delayed Price · Currency is USD
0.1296
0.00 (0.00%)
Nov 5, 2025, 4:00 PM EST
Voyageur Pharmaceuticals Market Cap
Voyageur Pharmaceuticals has a market cap or net worth of $18.93 million as of November 6, 2025. Its market cap has increased by 185.64% in one year.
Market Cap
18.93M
Enterprise Value
18.29M
Revenue
8.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since March 10, 2017, Voyageur Pharmaceuticals's market cap has increased from 3.53M to 18.93M, an increase of 435.77%. That is a compound annual growth rate of 21.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 18.94M | 107.29% |
| Dec 31, 2024 | 9.14M | 21.27% |
| Dec 29, 2023 | 7.54M | 1.58% |
| Dec 30, 2022 | 7.42M | 2.46% |
| Dec 31, 2021 | 7.24M | 58.26% |
| Dec 31, 2020 | 4.58M | 9.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 595.49M |
| Northwest Biotherapeutics | 373.25M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.64M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |